• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery

    3/20/24 11:40:01 PM ET
    $CERS
    $MRNA
    $PSNL
    $SQ
    EDP Services
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $CERS alert in real time by email

    On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering.

    The Block Inc Trade

    The sale, worth $3.5 million, was executed through Ark's flagship ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW) with a total of 42,608 shares sold. The value of the trade, calculated from the latest closing price of $81.46. Notably, at the time of writing, Bitcoin traded nearly 6.6% higher at $67,330.71.

    Ark has sold Block shares in every trading session of the current week. On Monday, Ark sold Block shares worth $8.95 million and on Tuesday, the firm sold $7.5 million worth. For the week, including Wednesday’s sale, the total stands at $19.95 million.

    Notably, Wood came to the defense of Block when the short seller Hindenburg issued an adverse report against the company.

    Other Key Trades:

    Ark Invest bought shares of Cerus Corp (NASDAQ:CERS). The firm also bought shares of Personalis Inc (NASDAQ:PSNL).

    Ark also purchased shares of Moderna Inc (NASDAQ:MRNA) through its ARKK fund. Shares of Twilio Inc (NYSE:TWLO) were sold from both the ARKK and ARKW portfolios.

    Read Next: Whopping $33.8 Million Worth Of Dogecoin Shifted To Robinhood — And People Suspect This Person Could Be Behind It


    Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal


    The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


    Get the next $CERS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CERS
    $MRNA
    $PSNL
    $SQ

    CompanyDatePrice TargetRatingAnalyst
    Twilio Inc.
    $TWLO
    4/6/2026$160.00Hold → Buy
    Jefferies
    Twilio Inc.
    $TWLO
    3/2/2026Hold → Buy
    TD Cowen
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Moderna Inc.
    $MRNA
    1/7/2026$34.00Neutral
    UBS
    Twilio Inc.
    $TWLO
    1/5/2026$165.00Buy
    BTIG Research
    Twilio Inc.
    $TWLO
    1/5/2026$148.00Overweight → Neutral
    Piper Sandler
    Moderna Inc.
    $MRNA
    12/12/2025$30.00Hold
    Jefferies
    Personalis Inc.
    $PSNL
    12/2/2025$11.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CERS
    $MRNA
    $PSNL
    $SQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026

    Podium presentation on NeXT Personal® monitoring neoadjuvant therapy in colorectal cancer; Real-world data from 10,000 patients reinforce industry-leading sensitivity; Data presented for a new NeXT Personal feature for monitoring resistance mutations Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research (AACR) Annual Meeting. The data, spanning one oral podium presentation and three posters, underscore the use of the NeXT Personal ultrasensitive ctDNA assay in monitoring treatment response, identifying early recurrence, and tracking the emergence

    4/21/26 6:00:00 AM ET
    $PSNL
    Medical Specialities
    Health Care

    Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

    Cerus Corporation (NASDAQ:CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event. A repl

    4/16/26 4:01:00 PM ET
    $CERS
    EDP Services
    Technology

    Twilio Flex Now Available as an Embeddable Contact Center

    New Flex SDK and Salesforce Voice integration accelerate contact center deployment with human-in-the-loop capabilities User + Usage pricing model combines low per-seat licenses with consumption-based fees, delivering flexibility to scale with seasonal needs Twilio (NYSE:TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, today announced a new Flex SDK for businesses to integrate contact center capabilities directly into their existing applications, including voice capabilities for Agentforce Service. Today's launch also adds enhanced insights, a flexible User + Usage pricing model that is available for Flex deployments on a

    4/16/26 9:00:00 AM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    $CERS
    $MRNA
    $PSNL
    $SQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gregory Dean A. bought $31,250 worth of shares (25,000 units at $1.25), increasing direct ownership by 41% to 86,725 units (SEC Form 4)

    4 - CERUS CORP (0001020214) (Issuer)

    8/25/25 3:25:00 PM ET
    $CERS
    EDP Services
    Technology

    Chief Executive Officer Bancel Stephane bought $5,004,318 worth of shares (160,314 units at $31.22) (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    3/4/25 4:27:16 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Sagan Paul bought $1,004,251 worth of shares (31,620 units at $31.76) (SEC Form 4)

    4 - Moderna, Inc. (0001682852) (Issuer)

    3/4/25 4:24:36 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CERS
    $MRNA
    $PSNL
    $SQ
    SEC Filings

    View All

    SEC Form 144 filed by Twilio Inc.

    144 - TWILIO INC (0001447669) (Subject)

    4/21/26 4:35:56 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Cerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - CERUS CORP (0001020214) (Filer)

    4/21/26 4:21:10 PM ET
    $CERS
    EDP Services
    Technology

    SEC Form DEFA14A filed by Personalis Inc.

    DEFA14A - Personalis, Inc. (0001527753) (Filer)

    4/2/26 4:07:10 PM ET
    $PSNL
    Medical Specialities
    Health Care

    $CERS
    $MRNA
    $PSNL
    $SQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Twilio upgraded by Jefferies with a new price target

    Jefferies upgraded Twilio from Hold to Buy and set a new price target of $160.00

    4/6/26 8:41:19 AM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Twilio upgraded by TD Cowen

    TD Cowen upgraded Twilio from Hold to Buy

    3/2/26 8:29:57 AM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Barclays resumed coverage on Moderna with a new price target

    Barclays resumed coverage of Moderna with a rating of Equal Weight and set a new price target of $25.00

    1/28/26 7:18:07 AM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CERS
    $MRNA
    $PSNL
    $SQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Shipchandler Khozema

    4 - TWILIO INC (0001447669) (Issuer)

    4/8/26 4:27:14 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Mock James M

    4 - Moderna, Inc. (0001682852) (Issuer)

    4/6/26 4:45:51 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Viggiano Aidan

    4 - TWILIO INC (0001447669) (Issuer)

    4/6/26 4:29:38 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    $CERS
    $MRNA
    $PSNL
    $SQ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CERS
    $MRNA
    $PSNL
    $SQ
    Financials

    Live finance-specific insights

    View All

    Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

    Cerus Corporation (NASDAQ:CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event. A repl

    4/16/26 4:01:00 PM ET
    $CERS
    EDP Services
    Technology

    Twilio to Announce First Quarter 2026 Results on April 30, 2026

    Twilio Inc. (NYSE:TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, today announced that its first quarter 2026 results will be released on Thursday, April 30, 2026, after market close. Twilio will host a conference call at 2:00 p.m. (PT) / 5:00 p.m. (ET) on Thursday, April 30, 2026 to discuss its results with the investment community. Investors and analysts can register for the webcast at https://edge.media-server.com/mmc/p/sfj2jo9i, and the live webcast and replay will also be available on the Twilio Investor Relations website at https://investors.twilio.com. The replay will be available until 11:59 p.m. (ET) on April 30, 2

    4/9/26 4:05:00 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

    2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial Execution and Disciplined Operational Management Cerus Corporation (NASDAQ:CERS) announced today financial results for its full year and fourth quarter ended December 31, 2025. "Our strong 2025 results reflect our disciplined execution, as we continued to deliver on our mission of safeguarding the world's blood supply. This past year, we achieved our highest annual kit shipments, enabling an estimated 600,000 patients worldwide to receive INTERCEPT-treated blood components," said William "Obi" Greenman, Cerus' pres

    3/2/26 4:01:00 PM ET
    $CERS
    EDP Services
    Technology

    $CERS
    $MRNA
    $PSNL
    $SQ
    Leadership Updates

    Live Leadership Updates

    View All

    Twilio Appoints Doug Robinson to Board of Directors

    Twilio (NYSE:TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, today announced that Doug Robinson has been appointed to the Twilio Board of Directors, effective immediately. Robinson is a seasoned executive, previously holding the position of Co-President of Workday. He brings decades of experience in scaling global organizations, specifically overseeing GTM efforts, allowing him to provide a unique perspective as Twilio focuses on expanding its platform and retaining customers. "Doug has a proven track record of scaling global organizations with immense rigor and discipline," said Khozema Shipchandler, CEO of Twilio. "Duri

    3/24/26 4:15:00 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption

    Dr. Chen expands his leadership role to serve as President while continuing to serve as Chief Medical Officer (CMO), unifying R&D innovation with operational execution as Personalis defines the next era of ultrasensitive MRD testing Personalis, Inc. (NASDAQ:PSNL), a leader in advanced genomics for precision oncology, today announced the promotion of Richard Chen, M.D., M.S., to the position of President. Dr. Chen will continue to serve as CMO of Personalis in addition to his new role. The appointment comes at a critical inflection point as Personalis transitions from a pioneering R&D powerhouse into a market leader in Minimal Residual Disease (MRD) testing. Under Dr. Chen's scientific l

    3/17/26 4:00:00 PM ET
    $PSNL
    Medical Specialities
    Health Care

    Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

    William "Obi" Greenman to become Executive Chairman Leadership changes to take effect July 1, 2026 Cerus Corporation (NASDAQ:CERS) today announced that Vivek Jayaraman, Cerus' chief operating officer, will be promoted to president and chief executive officer, effective July 1, 2026. William "Obi" Greenman will become executive chairman of the board of directors. At the time of his appointment, Mr. Jayaraman will join the Board of Directors. "Following a thorough succession planning process, this transition represents a natural step as we prepare for the next phase of growth at Cerus," said Frank Witney, lead independent director on the Cerus Board of Directors. "The Board and I are de

    3/16/26 4:05:00 PM ET
    $CERS
    EDP Services
    Technology

    $CERS
    $MRNA
    $PSNL
    $SQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Block Inc.

    SC 13G/A - Block, Inc. (0001512673) (Subject)

    11/12/24 1:23:34 PM ET
    $SQ
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Twilio Inc.

    SC 13G - TWILIO INC (0001447669) (Subject)

    11/12/24 10:34:15 AM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Cerus Corporation

    SC 13G/A - CERUS CORP (0001020214) (Subject)

    11/12/24 9:53:11 AM ET
    $CERS
    EDP Services
    Technology